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Characteristics of adolescents living with
HIV receiving care and treatment services
in antiretroviral therapy clinics in
Cambodia: descriptive findings from a
cross-sectional study
Siyan Yi1,2,3* , Sovannary Tuot2, Khuondyla Pal2, Vohith Khol4, Say Sok2,5, Pheak Chhoun2, Laura Ferguson6
and Gitau Mburu7
Abstract
Background: Adolescents living with HIV experience worse HIV care outcomes compared to adults, especially
during transition from pediatric to adult care. However, data regarding adolescents are limited. This paper describes
and compares characteristics of male and female adolescents living with HIV preparing for transition from pediatric
to adult care in Cambodia.
Methods: This cross-sectional study was conducted in August 2016 among 328 adolescents aged 15–17, randomly
selected from 11 antiretroviral therapy (ART) clinics. Data were collected using a structured questionnaire, and
descriptive analyses were conducted to compare characteristics of male and female adolescents.
Results: Of total, 55.2% were male, and 40.8% were living with parents. Majority (82.6%) got HIV infection from their
mothers. Overall, adolescents had received ART for an average of 8.4 years, and HIV care for 9.5 years. Additionally, 82.4%
were on first line ART regimen. Mean CD4 count from the most recent test was 672 cells/mm3, and viral load was 7686
copies/mL. Overall, 95.6% were adherent to ART on Visual Analogue Scale. About half (50.7%) had never disclosed their
HIV status to anyone, while the remaining had disclosed it to their siblings (24.2%), friends (13.0%), schoolteachers
(2.4%), or other (5.8%). A fifth reported having had boy or girlfriends, but few (2.1%) had ever had sexual intercourse.
Females were more likely to have been engaged in sexual intercourse, and none reported having used a condom in
their last intercourse. Few participants reported having ever used tobacco (1.8%), or any kind of illicit drugs (0.9%), but
almost a fifth (20.7%) had a history of alcohol use. The majority (82.1%) were aware that they were receiving ART. HIV-
related knowledge was suboptimal among the sample.
Conclusions: This study provides a snapshot of immunological, virological, adherence, and disclosure outcomes that
should be tracked during and following healthcare transition to evaluate the effectiveness of the transition program.
Findings showed high ART adherence, low likelihood of disclosure outside of family circles, sub-optimal condom use,
and poor knowledge of HIV. To provide individualized support for healthcare transition, pediatric and adult clinics need
to ensure that these characteristics are taken into account.
Keywords: Adolescents, HIV, Healthcare transition, Pediatric care, Adult services, Cambodia
* Correspondence: siyan@doctor.com
1Saw Swee Hock School of Public Health, National University of Singapore
and National University Health System, Singapore, Singapore
2KHANA Center for Population Health Research, No. 33, Street, Phnom Penh
71, Cambodia
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yi et al. BMC Health Services Research  (2018) 18:781 
https://doi.org/10.1186/s12913-018-3580-1
Background
Over 2.1 million adolescents (aged 10–19 years) are living
with HIV globally [1], and this number continues to grow,
mainly due to ongoing mother-to-child transmission,
increased survival as a result of antiretroviral therapy
(ART), and sexual transmission among adolescents [2].
In Cambodia, where HIV prevalence was 0.28% among
the general population aged 15–49 years in 2014 [3],
there were an estimated 8512 children and adolescents
living with HIV at the end of 2013 [4].
Although there have been remarkable achievements in
the global HIV response, the progress in HIV prevention,
care, and treatment among adolescents aged 10–19 years
is lagging behind other age groups [5, 6]. While mortality
among people living with HIV in all other age groups is
decreasing, that of adolescents living with HIV is increas-
ing [6]. Reasons for poor HIV outcomes in adolescents
have included poor long-term immunologic recovery [7],
poor adherence to ART due to treatment fatigue and
marginalization [8], delayed diagnosis [9], stigma [10, 11],
difficulties with disclosure [12, 13], lack of awareness of
serostatus [14], denial of care by legal parents or guardians
for a myriad of personal reasons such as fear of the child’s
or parents’ HIV status disclosure and/or structural factors
such as poverty or alternative beliefs in treatment [15],
and restrictive legal and policy environments that impede
their own ability to consent to services [16].
Of particular concern is the unique issue of transition
from pediatric to adult clinics. The circumstances and
characteristics of adolescents during transition is increas-
ingly being recognized as a significant determinant of their
HIV care outcomes [17]. For instance, transition between
pediatric to adult services is often accompanied by signifi-
cant loss to follow-up [18]. During this time, adolescents are
gaining mental, physical maturity, independence [19, 20],
and seeking autonomy and independence from their family
and attachment to their peer groups [21]. These cir-
cumstances may intersect with substance use, self-de-
termination, burgeoning responsibility, mental health
issues, psychosocial delays, sexual behaviors, and child-
bearing to affect their adherence to ART, viral suppres-
sion, and eventual ability to transition successfully into
adult care [20–24]. The magnitude of the HIV epidemic
among adolescents and their relatively poor clinical
outcomes, especially during transition, are projected to
worsen unless adequate steps are taken and appropriate
transition models are considered to address this popu-
lation’s unique needs [2, 21, 25].
Healthcare transition can be defined as ‘the purposeful,
planned movement of adolescents and young adults with
chronic medical conditions from a child-centered to an
adult-oriented health care system’ [21, 23, 24]. According to
the World Health Organization (WHO), healthcare transi-
tion preparedness is determined by adolescents’ ability to
demonstrate basic healthcare awareness, awareness of their
status, understanding their disease, and development of
own health management skills [26]. However, number of
research regarding adolescents’ healthcare transition in the
context of HIV, especially in low- and middle-income coun-
tries is relatively limited [6, 24]. This is particularly concern-
ing given that adolescents living with HIV in low- and
middle-income countries are disproportionately affected by
disparities in HIV mortality [27]. Scarcity of data around
transition is further exacerbated by current demographic
disaggregation of adolescents into 10–14 and 15–24 [1, 6],
which limits the availability of data regarding the needs,
conditions, and situations of under-18 year olds living with
HIV, especially in resource-limited settings [21, 28, 29].
Without adequate data, understanding the circumstances
of adolescents living with HIV and tailoring services, which
are known to improve treatment outcomes [30], will be
challenging. Generating data around adolescents’ transition
readiness is therefore critical to informing appropriate
policies and services.
In Cambodia, transition of adolescents from pediatric
into adult care is supposed to occur at the age of 15 years.
However, in practice, a large proportion of adolescents
living with HIV aged 15–17 remain in pediatric clinics.
Exploratory studies among adolescents in healthcare transi-
tion have only started emerging in the last three years. In
these studies, stigma and a lack of confidentiality were
the main challenges for adolescents during the transi-
tion [31, 32]. However, these studies were of limited
scope with small sample sizes, limiting their potential
to inform service delivery and policy interventions [33].
The extent to which transition experiences are affected
by the differential sexual debut and maturation across
gender [6] is unknown, yet this information would be
important to tailor healthcare transition. In response to
this gap, a larger study was designed to explore adoles-
cents’ preparedness for the transition from pediatric to
adult HIV care settings in Cambodia. This paper aimed to
describe the characteristics and level of preparedness for




This study was conducted in 2016 and consisted of a
cross-sectional survey, complemented with data from
routine clinical data retrieved from medical records in
the selected ART clinics. The details of the larger study
have been published elsewhere [34, 35].
Study population
This study included adolescents living with HIV, who
were accessing services from 11 pediatric ART clinics
and being prepared for transition to adult HIV care.
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Adolescents were included in the study if they were: (1)
aged between 15 and 17 years; (2) receiving HIV treat-
ment and care services from the selected ART clinics;
(3) able to communicate in Khmer; (4) allowed by a con-
senting parent or guardian to participate; (5) able to
present themselves on the day of the interview; and (6)
sufficiently physically and mentally stable to participate
in the study.
Study sites
Study sites were selected from a universe of 39 ART
clinics that provided treatment and care to adolescents
living with HIV nationally. Of these, ART sites that pro-
vided treatment and care to fewer than 10 adolescents
(n = 24) were excluded to reduce data collection cost.
The remaining 11 ART clinics that were providing care
and treatment to 598 adolescents living with HIV in the
capital city and 10 provinces were included in the study.
These diverse sites were scattered throughout the country
and were located in rural, urban, and peri-urban areas.
Sample size
The sample size was calculated using a cluster-sampling
method [36] and was based primarily on an assumption
that 60% of the sampled adolescents would possess a
high level of preparedness to transition to adult care.
Assuming a design effect of 1.4 and a 10% dropout or
refusal rate, a minimum sample size of 320 was re-
quired for the study with a confidence interval of 4.3%.
Sampling procedure
A two-stage 30 × 10 cluster sampling method was used
[37]. Because the size of the ART clinics varies, clusters
were selected using probability proportional to size sam-
pling method [36], which ensured that adolescents in
larger sites had the same probability of being included in
the sample as those in smaller sites. A list of all ART
sites in the country was compiled from which those with
more than 10 adolescents was used to select the clusters.
The adolescent population size of each ART clinic and
sampling interval was then determined, and a random
number was chosen as a starting point on the list to
begin cluster selection.
Participant recruitment
Local coordinators worked closely with the database offi-
cer of each ART clinic to randomly select the eligible
participants from the database using a table of random
numbers. The list of selected adolescents was compiled.
These adolescents were allocated a unique identification
number, which was based around their clinic ID. As part
of initial screening process, the local study coordinators
contacted adolescents through their parent or guardian
to inform them about the research objectives. Those
who accepted the invitation to participate were provided
with an appointment with details regarding the place,
date, and time of the interview. Twelve selected adolescents
refused the participation due to their school commitment
and were replaced by the next adolescents on the name list.
Variables and measurements
The study collected a variety of data and measures informed
by existing literature [23, 38]. A structured questionnaire
was administered to gather data related to demographic
characteristics, ART clinic category (pediatric or adult),
ART and immunological and virological statuses, adher-
ence to ART, level of preparedness to be transferred to an
adult clinic, healthcare coverage and access, HIV know-
ledge, substance use, sexual behaviors, access to health
services, disclosure, among others.
To measure adherence to ART, we used Visual Analogue
Scale [39]. The participant was asked to think back over the
past three days and identify the times when he or she either
missed a dose or took it at the wrong time. The interviewer
showed the participant a copy of the scale. While placing
their finger on the appropriate number, the interviewer told
the participant that, if he or she had taken all medicine
doses, to point to 10. If the participant missed all the medi-
cine, he or she would point to 0—if the scale is marked off
at 4, then the percentage adherence would be 40%.
The questionnaire was pretested and validated for con-
tents and language with 20 adolescents at one ART site
that was not part of the study, and subsequently revised
based on their feedback.
Data collection
Data were collected by two teams of interviewers and
moderators, who were experienced in data collection,
and who had been trained on the study protocol, inter-
view skills, and research ethics including specific issues
related to research with human participants [40] and
young people [41]. These teams were monitored by field
supervisors who reviewed questionnaires at the end of
each day to ensure entries were appropriately completed.
Questionnaires with incomplete or queried entries were
re-validated with participants within 24 h. In addition,
we collected immunological and clinical data, including
ART history and laboratory values for CD4 count and
viral load from medical records.
Data analyses
Data were double-entered by data clerks as continuous
or as coded categorical variables into Epi Data version 3
(Odense, Denmark). Frequency distribution of responses
was determined for ordinal and categorical variables, and
a mean value with a standard deviation (SD) was calcu-
lated for continuous variables. Descriptive analyses were
conducted to determine the proportion of adolescents
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with each variable. Chi-square test, Fisher’s exact test, or
Student’s t-test, characterized based on the nature of vari-
ables being analysed, were used to compare relevant vari-
ables between male and female adolescents. P-values of
less than 0.05 were considered to be statistically signifi-
cant. SPSS version 22 (IBM Corporation, New York, USA)
was used for all statistical analyses.
Ethical consideration
This study was conducted in keeping with guidelines
related to research involving human subjects [40]. All
researchers and data collectors were re-trained on the
ethical issues prior to data collection. At the eligibility
screening stage, verbal assent from adolescents and verbal
consent from a parent or guardian was obtained. Partici-
pants were interviewed without their parent/guardian in a
private room. In case of need, his/her parent/guardian was
called for clarification. Confidentiality was strictly protected
by removing all personal identifiers from the questionnaires
and assigning each participant a unique code. All partici-
pants were provided with a token of 5 USD for transporta-
tion and time compensation. The study protocol and tools
were approved by the National Ethics Committee for
Health Research, Ministry of Health in Cambodia (Ref:
297NECHR).
Results
Characteristics of the study sample
Table 1 shows socio-demographic characteristics of the
study sample. The study included 328 adolescents living
with HIV with a mean age of 15.8 (SD = 0.8) years. Male
adolescents comprised 55.2% of the sample. About half
(50.7%) reported that they had completed secondary
school. Participants were currently living with parents
(40.8%), relatives (33.6%), grandparents (15.7%), in an or-
phanage (8.1%), or with Buddhist monks, neighbours, or
foster parents (1.8%). Less than half (47.5%) reported
that their mother was still alive, and 42.6% reported that
their father was still alive. The formal education level of
parents was generally low, with only 19.4% of mothers
and 20.9% of fathers having completed high school or
university education. The participants reported that their
main caregivers were their biological parents (55.6%),
relatives (32.2%), siblings (6.7%), orphanage/NGO staff
(3.3%), or grandparents (2.2%). More than half of them
(52.5%) did not know the education levels of their care-
givers other than their parents, while 21.6% reported
that their main caregiver had completed high school or
university education. Besides the father’s education
level (p = 0.04) and main caregiver’s education level
(p ≤ 0.001), there was no statistically significant differ-
ence between male and female participants in other
variables.
ART, immunological and virological statuses, and
healthcare coverage
Table 2 shows that 82.4% were on first line ART. On
average, the participants had received treatment and care
services from an ART clinic for 9.5 (SD = 3.3) years, and
received ART for 8.4 (SD = 3.3) years. The average travel
expenditure to the ART clinic was $3.4 (SD = 3.9). In
addition, 95.6% were adherent to ART based on self-re-
ported Visual Adherence Scale.
The mean CD4 count in the first test was 632 (SD =
506) cells/mm3, and in the most recent test was 672
(SD = 295) cells/mm3. Mean viral load count in the ini-
tial test was 44,691 (SD = 161,304) copies/mL, and in the
most recent test was 7686 (SD = 48,682) copies/mL. The
proportion of participants with viral suppression (viral
load count < 1000 copies/mL) was 76.8%. No significant
difference was found in ART and immunological and
virological statuses among male and female participants.
Less than half (44.8%) of the participants reported that
their family was able to cover their health expenses without
support. About one-third (34.2%) had an ID poor card;
38.4% had access to the health equity fund; and only 1.8%
had their treatment covered by a health insurance scheme.
Significant gender differences was found in the proportion
of family having an ID poor card (p = 0.04), access to health
equity fund (p ≤ 0.001), and having their treatment covered
by a health insurance scheme (p = 0.02).
Awareness and disclosure of HIV status
As shown in Tables 3, 94.5% were aware that they were
living with HIV. About half (49.1%) of the participants
had disclosed their HIV status to someone in their social
circles, mostly to siblings or friends. Half (50.7%) had
never disclosed their HIV status to anyone. In addition,
82.6% responded that they had acquired the HIV infec-
tion from their mothers, while 17.4% did not know the
source of their HIV infection. When asked about modes
of HIV transmission, 96.7% knew at least one mode of
transmission. Significant gender differences were found in
knowledge of HIV transmission modes (p = 0.04 for
mother to child transmission, and p = 0.001 for blood
transfusion) and disclosure status (p = 0.03).
Sexual behaviors and substance use
As shown in Table 4, about a fifth (20.7%) of participants
reported having had a boy or girlfriend, but only 2.1%
reported having had sexual intercourse in the past
12 months. None of those who had sexual experience re-
ported using a condom in their last intercourse. Very few
reported having used tobacco (1.8%), or any kind of illicit
drugs (0.9%), but almost a fifth had a history of alcohol
use. Apart from experience in sexual intercourse (p =
0.04), there was no significant gender difference in other
variables.
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n (%) n (%) n (%) P-value*
Mean age (in years) 15.9 ± 0.8 15.8 ± 0.8 16.0 ± 0.8 0.06
Level of formal education 0.76
Primary school or lower 92 (28.0) 50 (20.7) 42 (26.4)
Secondary school 168 (51.3) 86 (50.9) 82 (51.6)
High school or higher 68 (20.7) 33 (19.5) 35 (22.0)
Currently living with: 0.33
Parents 140 (42.7) 73 (43.2) 67 (42.1)
Grandparents 49 (14.9) 29 (12.7) 20 (12.6)
Relatives 106 (32.3) 54 (32.0) 52 (32.7)
In an orphanage 27 (8.2) 12 (7.1) 15 (9.4)
Other 6 (1.8) 1 (0.6) 5 (3.1)
Mother is still alive 0.18
No 167 (60.9) 80 (47.3) 87 (54.7)
Yes 161 (49.1) 89 (52.7) 72 (45.3)
Mother’s education level 0.12
No education 20 (12.7) 7 (8.1) 13 (18.1)
Primary school 53 (33.5) 27 (31.4) 26 (36.1)
Secondary school 24 (15.2) 14 (16.3) 10 (13.9)
High school or higher 24 (15.2) 12 (14.0) 12 (16.7)
Don’t know 37 (23.4) 26 (30.2) 11 (15.3)
Father is still alive 0.82
No 198 (60.4) 101 (59.8) 97 (61.0)
Yes 130 (39.6) 68 (40.2) 62 (39.0)
Father’s education level 0.04
No education 9 (5.6) 4 (6.2) 3 (4.3)
Primary school 33 (26.2) 12 (18.8) 21 (33.9)
Secondary school 18 (14.3) 8 (12.5) 10 (16.1)
High school or higher 28 (24.3) 9 (14.1) 14 (22.6)
Don’t know 45 (35.7) 31 (48.4) 14 (22.6)
Main daily caregiver: 0.57
Parent 187 (57.0) 102 (60.4) 85 (53.5)
Grand parent 5 (1.5) 2 (1.2) 3 (1.9)
Sibling 24 (7.3) 9 (5.3) 15 (9.4)
Relatives 100 (30.5) 50 (29.6) 50 (31.4)
Orphanage/NGO staff 12 (3.7) 6 (3.6) 6 (3.8)
Main caregiver’s education level: < 0.001
Primary school or lower 14 (7.2) 2 (2.1) 12 (12.1)
Secondary school 40 (20.5) 8 (8.3) 32 (32.3)
High school 11 (5.6) 6 (6.2) 5 (5.1)
University or higher 29 (14.9) 16 (16.7) 13 (13.1)
Don’t know 101 (51.8) 64 (66.7) 37 (37.4)
Values are number (%) for categorical variables and mean (standard deviation) for continuous variables
*Chi-square test or Fisher’s exact test as appropriate was used for continuous variables, and Student’s t-test for continuous variables
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HIV knowledge
Table 5 shows that level of HIV knowledge among ado-
lescents in this study was generally high, although
there were still a good number of adolescents who did
not agree or know HIV is a virus that attacks a per-
son’s immune system (19.8%), the function of CD4
cells of fighting infection (38.1%), or the amount of
HIV in a person’s blood is called viral load (51.2%). In
addition, 49.8% believed that there is a cure for AIDS.
However, the majority of the participants were of the
view that you cannot tell a person has HIV by looking
at him or her (82%), and that it is not okay for people
living with HIV to miss their medicines (83.5%). A
significant number disagreed with the statement that
“If people living with HIV take medicines, they don’t
have to use condoms” (58.8%) and “If sexual partners
are both living with HIV, they don’t have to use a con-
dom” (47.3%), among other findings. Significant gender
differences were found in HIV knowledge, especially
in understanding about CD4 (p = 0.03), viral load (p =
0.004), condom use (p = 0.005), and missing ARV dose
(p = 0.02).








n (%) n (%) n (%) P-value*
Antiretroviral therapy (ART)
Mean travel time to ART clinic (min) 48.2 ± 43.4 46.1 ± 41.2 55.5 ± 45.5 0.36
Type of ART regimen 0.91
First line 183 (82.4) 140 (82.8) 131 (82.4)
Second line 36 (16.2) 29 (17.2) 27 (17.6)
Time since ART started (in years) 8.2 ± 3.3 8.3 ± 3.4 7.8 ± 3.3 0.20
Mean cost to travel to ART clinic (USD) 3.4 ± 3.9 3.5 ± 3.9 3.3 ± 4.0 0.61
Visual Adherence Scale (%) 95.4 ± 9.6 95.3 ± 9.6 95.4 ± 9.7 0.91
Immunological and virological status
Initial CD4 count (mean cells/mm3) 632 ± 1101 777 ± 1460 632 ± 460 0.35
Latest CD4 count (mean cells/mm3) 672 ± 284 683 ± 314 660 ± 250 0.44
First viral load count (copies) 34,375 ± 13,958 37,868 ± 13,205 30,662 ± 14,748 0.64
Latest viral load count (copies) 9268 ± 6407 4103 ± 1573 14,759 ± 9041 0.13
Viral suppression 252 (76.8) 131 (77.5) 121 (76.1) 0.76
Healthcare access and coverage
Ability to cover health expenses 0.11
No 181 (55.2) 86 (50.9) 95 (59.7)
Yes 147 (44.8) 83 (49.3) 64 (40.3)
Family has an ID poor card 0.04
No 190 (57.9) 88 (52.1) 102 (64.2)
Yes 112 (34.2) 63 (37.3) 49 (30.8)
Don’t know 26 (7.9) 18 (10.7) 8 (5.0)
Access to the health equity fund < 0.001
No 185 (56.4) 109 (64.5) 76 (47.8)
Yes 126 (38.4) 45 (35.7) 81 (50.9)
Don’t know 17 (5.2) 15 (8.9) 2 (1.3)
Covered by a health insurance scheme 0.02
No 289 (88.1) 148 (87.6) 141 (88.7)
Yes 6 (1.8) 0 (0.0) 6 (3.8)
Don’t know 33 (10.1) 21 (12.4) 12 (7.5)
Values are number (%) for categorical variables and mean (standard deviation) for continuous variables
*Chi-square test or Fisher’s exact test as appropriate was used for continuous variables, and Student’s t-test for continuous variables
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Discussion
This paper reports important characteristics of adoles-
cents living with HIV aged 15–17 years old, who remained
in pediatric care and in preparation for transition into
adult HIV care. Several findings which are central to
WHO’s definition of healthcare transition readiness are
notable. Some gender differences in these characteristics
were also identified.
In this study, the majority of adolescents were still on
first line treatment, and most reported a high level of
adherence to ART on Visual Analogue Scale (95.4%).
Adherence is a significant determinant of treatment suc-
cess [7], and an indicator of healthcare transition readi-
ness as part of self-health management [26, 42]. Our
finding of high ART adherence among the sample is a
departure from frequent reports of much lower rates of
adherence among adolescents living with HIV studied
elsewhere [7, 24] and low level of adherence among chil-
dren and adolescents living with HIV in general [43]. In
other studies, treatment fatigue [8], side effects, anticipated
stigma, fear of HIV status disclosure, psychological factors,
client-provider relationship [24, 44, 45], and inconsistent
daily routine [46] contributed to low adherence among
older adolescents. A recent review also suggested that only
70% of adolescents and young adults living with HIV in
Africa and Asia receiving ART were adherent to it [47].
A possible explanation to the high level of adherence
reported in our study may be related to the widely avail-
able free HIV services including ART and social support
(e.g. 34.2% and 38.2% having a poor ID card and health
equity fund, respectively), despite the fact that many had
lost at least one of their parents and were from a poor
family background. Availability of social and financial pro-
tection can affect treatment adherence and preparation to
transition [24, 46]. Likewise, inability to cover medical pre-
scription, partial insurance coverage and other economic
barriers, and lack of access to insurance, among others,
are threats to successful healthcare transition, even among
Table 3 Awareness and disclosure of HIV status among







n (%) n (%) n (%) P-value*
General understanding about HIV and AIDS
What is your disease? 0.19
HIV/AIDS 310 (94.5) 157 (92.9) 153 (96.2)
Don’t know 18 (5.5) 12 (7.1) 6 (3.8)
Do you know how is this disease transmitted?
Don’t know 8 (2.6) 5 (3.2) 3 (2.0) 0.5
Mother to child 207 (67.4) 114 (72.0) 95 (62.1) 0.04
Unprotected sex 236 (76.1) 119 (75.8) 117 (76.5) 0.89
Sharing needles 178 (57.4) 90 (57.3) 88 (57.5) 0.97
Blood transfusion 191 (61.6) 82 (52.2) 109 (71.2) 0.001
Other 65 (21.0) 35 (22.3) 30 (19.6) 0.56
Awareness about self and disclosure
Do you know how you have been infected? 0.97
From mother 256 (82.6) 189 (82.2) 127 (83.0)
Don’t know 54 (17.4) 28 (17.8) 26 (17.0)
Do you know what kind of medicine you have received? 0.16
Pre-ART 6 (1.9) 1 (0.6) 5 (3.3)
ART 268 (86.5) 141 (89.2) 127 (83.6)
Don’t know 36 (11.6) 16 (10.1) 20 (13.2)
Have you ever disclosed your HIV status to anyone? 0.03
None 167 (54.0) 77 (48.7) 90 (59.6)
Siblings 72 (23.3) 47 (29.7) 25 (16.6)
School teachers 6 (1.9) 3 (1.9) 3 (2.0)
Friends 44 (14.2) 18 (11.4) 26 (17.2)
Other (please specify) 20 (6.5) 13 (8.2) 7 (4.6)
Values are number (%) for categorical variables and mean (standard deviation)
for continuous variables
*Chi-square test or Fisher’s exact test as appropriate was used for continuous
variables, and Student’s t-test for continuous variables
Table 4 Sexual behaviors and substance use among







n (%) n (%) n (%) P-value*
Sexual behaviors
Had a boy (girl) friend in the past 12 months 0.41
No 260 (79.3) 137 (81.1) 123 (77.4)
Yes 68 (20.7) 32 (18.9) 36 (22.6)
Had sexual intercourse in the past 12 months 0.04
No 321 (97.9) 168 (99.4) 153 (96.2)
Yes 7 (2.1) 1 (0.6) 6 (3.8)
Condom use at last sexual intercourse NA
No 7 (100) 1 (100) 6 (100)
Yes 0 (0.0) 0 (0.0) 0 (0.0)
Substance use
Ever smoked tobacco 0.12
No 322 (98.2) 164 (97.0) 158 (99.4)
Yes 6 (1.8) 5 (3.0) 1 (0.6)
Ever used alcohol 0.07
No 267 (81.4) 144 (85.2) 123 (77.4)
Yes 61 (18.6) 25 (14.8) 36 (22.6)
Ever used any kind of illicit drugs 0.07
No 325 (99.1) 169 (100) 156 (98.1)
Yes 3 (0.9) 0 (0.0) 3 (1.9)
Values are number (%) for categorical variables and mean (standard deviation)
for continuous variables
*Chi-square test or Fisher’s exact test as appropriate was used for continuous
variables and Student’s t-test for continuous variables
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n (%) n (%) n (%) P-value*
HIV is a virus that attacks a person’s immune system 0.45
True (correct) 263 (80.2) 140 (82.8) 123 (77.4)
False 44 (13.4) 20 (11.8) 24 (15.1)
Don’t know 21 (6.4) 9 (5.3) 12 (7.5)
The cells of the immune system that fight infection are called CD4 cells 0.03
True (correct) 203 (61.9) 116 (68.6) 87 (54.7)
False 22 (6.7) 8 (4.7) 14 (8.8)
Don’t know 103 (31.4) 45 (26.6) 58 (36.5)
The amount of HIV in a person’s blood is called viral load 0.004
True (correct) 160 (48.8) 97 (57.4) 63 (39.6)
False 26 (7.9) 13 (7.7) 13 (8.2)
Don’t know 142 (43.3) 59 (34.9) 83 (52.2)
There is a cure for AIDS 0.38
True (correct) 138 (42.1) 67 (39.6) 71 (44.7)
False 165 (50.3) 93 (53.8) 74 (46.5)
Don’t know 25 (7.6) 11 (6.5) 14 (8.8)
You can tell a person has HIV by looking at him or her 0.09
True (incorrect) 46 (14.0) 29 (17.2) 17 (10.7)
False 269 (82.0) 136 (80.5) 133 (83.6)
Don’t know 13 (4.0) 4 (2.4) 9 (5.7)
A person with HIV will stay healthy if their CD4 cells are high and their viral load is low 0.99
True (correct) 284 (86.6) 146 (86.4) 138 (86.8)
False 23 (7.0) 12 (7.1) 11 (6.9)
Don’t know 21 (6.4) 11 (6.5) 10 (6.3)
Even though a person with HIV may feel healthy, the virus can still be damaging his or her immune system 0.86
True (correct) 248 (75.6) 127 (75.1) 121 (76.1)
False 65 (19.8) 35 (20.7) 30 (18.9)
Don’t know 15 (4.6) 7 (4.1) 8 (5.0)
If sexual partners are both living with HIV, they don’t have to use condoms 0.07
True (incorrect) 61 (36.1) 64 (40.3)
False 89 (52.7) 66 (41.5)
Don’t know 19 (11.2) 29 (18.2)
If people living with HIV take medicine, they don’t have to use condoms 0.005
True (incorrect) 86 (26.2) 41 (24.3) 45 (28.3)
False 193 (58.8) 112 (66.3) 81 (50.9)
Don’t know 49 (14.9) 16 (9.5) 33 (20.8)
It is okay for people living with HIV to miss their medicines 0.02
True (incorrect) 43 (13.1) 14 (8.3) 29 (18.2)
False 277 (83.5) 148 (87.6) 126 (79.2)
Don’t know 11 (3.4) 7 (4.1) 4 (2.5)
Values are number (%) for categorical variables and mean (standard deviation) for continuous variables
*Chi-square test or Fisher’s exact test as appropriate was used for continuous variables and Student’s t-test for continuous variables
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adolescents who have ‘developmental readiness’ for transi-
tion, according to other research studies [21, 25, 48].
However, we noted that despite the high level of ad-
herence reported, the average viral load was high (7686
copies/mL). One of the possible explanations for this is
the time lag between the viral load and the adherence
measurements. While the adherence was assessed over
the last three days, medical records were used to deter-
mine the last viral load measurements, which take place
six monthly for new and unstable patients and annually
for stable patients. It is also possible that the ART adher-
ence levels reported in our study were overestimated
due to social desirability bias and the subjective nature
of the visual adherence scale, which may have led adoles-
cents to report higher than actual adherence. An assess-
ment of viral load levels using more objective methods
such as plasma drug levels will be required in future stud-
ies to ascertain levels of adherence. Although other studies
have reported loss to follow up, transfer out, and mortality
outcomes during and following transition [22, 49–51],
these data were not collected in our study and will need to
be tracked.
Our study suggests that, although most adolescents
were well informed of its nature and how they acquired
HIV, there were still significant gaps in the awareness of
HIV risk factors and some of the specifics related to viral
and immunological responses to HIV. The lack of ap-
propriate information has been reported in other studies
of adolescents transitioning into adult care [52]. While
lack of HIV knowledge is not unique among adolescents
living with HIV [52, 53], a good understanding of HIV
and its natural history is a critical part of treatment literacy
and self-management skills, and therefore gains promin-
ence in relation to older adolescents who are about to take
responsibility over their own health. As a consequence, and
in line with WHO’s understanding of transition readiness
[26], additional focus on HIV treatment literacy will be
required as part of the transition preparedness process.
Half of the adolescents had not disclosed their HIV
status to anyone, while 23.3% disclosed it to their sibling
and 14.2% to their friends, and 5.5% of the adolescents
did not know their HIV status. Adolescents require in-
formation and ongoing support to determine how, when,
and whom to disclose, enabling them to make informed
decisions, balancing the risks and benefits of disclosure
[54]. Studies of adolescents in transition clinics have
shown that adolescents face challenges with disclosure
[11]. Among both transitioning and other adolescents in
general, disclosure can lead to negative consequences of
rejection and stigmatization, even from the loved ones
[12, 13, 37, 55] and in other cases, it can open opportun-
ities for support from family members and intimate part-
ners [13], participation in peer-support groups [10], and
management of sexual risks [56]. It is widely accepted
that besides access to ART, adolescent patients need atten-
tion and care to their ‘physical and psychological needs’
from their immediate families and broader social groups
and adolescent-centered approaches to treatment [55],
and this is especially the case for those who have lost their
parent(s) – 60.9% of the adolescents in this study lost their
mothers and 60.4% their fathers. Because of these ten-
sions, efforts to assist adolescents to make informed deci-
sions on HIV status disclosure should form a central part
of regular communication with adolescents who are get-
ting ready for transition in Cambodia, as argued by other
researchers elsewhere [18].
In particular, there is a need to ensure that these ado-
lescents have the skills to disclose should they want to
[54]. In Cambodia, case managers, who manage transi-
tion for adolescents, have a significant role to play as a
source of advice, information, and communication skills
regarding disclosure by adolescents to their intimate part-
ners and other peers. This will require concerted efforts to
involve care givers to provide age-appropriate disclosure to
the few adolescents who were not aware of their status,
ensuring that those who are taking care of them, whether
biological parents or not, are involved and understand the
need for confidentiality. The need to strengthen adoles-
cents’ disclosure skills, especially as part of transition, is not
unique to Cambodia, having been identified elsewhere [46].
In addition, WHO recommends that age appropriate dis-
closure should accompany self-management of HIV [26].
Although adolescents in this study are generally not yet
sexually active, but given their transition into adulthood,
other important health knowledge and skills including
sexual and reproductive health such as use of condoms and
other birth control methods, use of illicit substances, and
healthy lifestyles should be included.
Few if any studies have explored gender differences
among transitioning adolescents. However, our data sug-
gested gender differences in some of the characteristics
of adolescents we studied. Although very few female
adolescents in the study were sexually active at their age,
which warrants cautious interpretation, more females
than males (or 6 female over 1 male) had had early sexual
debut in keeping with universal observations of earlier
sexual maturity among female adolescents living with HIV
[57]. Early sexual debut (sex before 15 years of age) is
more common among adolescent girls than boys in low-
and middle-income countries [6].
However, when we consider that female adolescents
living with HIV also seemed to have slightly lower levels
of general knowledge about HIV (Table 5), it raises con-
cerns regarding potential differences in sexual risks, for in-
stance of acquiring other HIV strains, or of transmitting the
virus unknowingly. Understanding sexual risks is a critical
part of ensuring that adolescents can independently man-
age their health. This suggests that healthcare transition
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interventions in the study context should address issues of
sexual risks, sexuality, and sexual negotiation among this
population as they mature. There is general consensus that
skills to empower adolescents to negotiate sexual relation-
ships are required as adolescents living with HIV physically
and psychologically develop [18, 58].
In addition, we emphasize that within these gender
categories, differences between older and younger adoles-
cents may also exist as documented elsewhere [59]. Age
alone may not always be a good predictor of healthcare
transition readiness, but should be considered alongside
individual adolescent’s evolving needs as part of a gradual
process in which they prepare for transition [24, 50, 60]. As
such the adolescents aged 15–17 preparing for transi-
tion in Cambodia and elsewhere should not be viewed
as a homogenous group, but rather a dynamic, hetero-
geneous group with differing gender and sexual prefer-
ences, stigma, adherence, and other social protection
and financial concerns within a diverse social context.
To provide individualized support for transition, pediatric
and adult clinics will need to ensure that these unique in-
dividual, social, and structural characteristics are taken
into account as argued by other researchers in Cambodia
and other contexts [17, 32, 46, 48, 61], ensuring that con-
text specific differences are taken into account. As other
researchers have argued, this requires different care and
treatment arrangements and options; transition planning,
process, procedure, and execution; inter-clinic communi-
cation and data sharing as well as coordination and com-
munication with and among adolescents, their parents
and caretakers, and multidisciplinary health and social
teams [24, 62, 63].
Finally, and while our study did not look at wider clinical
processes in depth, findings from other contexts suggest
that inter-clinic communication, clinical administration
processes, differences in care cultures, and personnel
deployments are all useful determinants of successful
transition [64], which should be taken into account in
the Cambodian context.
Study limitations
Some of the characteristics reported relied on self-reported
measures, which could be affected by social desirability and
recall biases. Our study was conducted among adolescents
living with HIV who were receiving health services in pub-
lic or NGO clinics; hence, our findings may not be general-
ized to all adolescents living with HIV in the country. In
addition, given the high cost in collecting data from low
volume clinics, adolescents who accessed care from clinics
providing care to less than 10 adolescents were excluded,
which may bias results, given that volume of patients is a
key determinant of provider competency [65] and patient
outcomes [66]. Our study was cross sectional in nature and
does not report the temporal variations of the variables. It
is possible that some of these measures could change
over time.
Conclusions
Understanding characteristics and circumstances of
adolescents living with HIV is critical in designing
adolescent-friendly services, including healthcare tran-
sition interventions. This study provides a snapshot of
immunological, virological, adherence, and disclosure
outcomes among adolescents preparing for transition
into adult clinics. Several findings are consistent with the
literature, including low likelihood of disclosure outside of
family circles, experience of HIV stigma, and sub-optimal
condom use and poor knowledge of HIV. This study adds
to the growing literature on immunological, virological,
HIV knowledge disclosure, and adherence characteristics of
adolescents preparing for transition from pediatric to adult
services. There is also added value in tracking these
and other characteristics during and following transi-
tion to understand the effectiveness of transition pro-
gram in Cambodia.
Based on WHO’s definition of transition preparedness
[26], our recommendations fall into three categories.
First is to strengthen adolescents’ ability to demonstrate
basic healthcare awareness through educating them on
HIV. Second is to enable adolescents to understand their
disease by specifically enabling those who are not disclosed
to know their HIV status. And third is to support them to
develop their health management skills by involving them
in tracking their own immunological, virological, and other
clinical outcomes as well as non-clinical outcomes such as
adherence and self-management skills.
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